FDA Enforcement
Class II
Terminated
Tina-quant C-Reactive Protein Gen.3, Catalog number 05172373190 - Product Usage: the in vitro quantitative determination of CRP in human serum and plasma on Roche automated clinical chemistry analyzers.
Recall: Z-0634-2021
·
Reported December 23, 2020
Enforcement
- Recall Number
- Z-0634-2021
- Event ID
- 86745
- Classification
- Class II
- Status
- Terminated
- Product Type
- Devices
- Firm
- Roche Diagnostics Operations, Inc.
- Voluntary / Mandated
- Voluntary: Firm initiated
- Initial Notification
- Letter
- Report Date
- December 23, 2020
- Initiation Date
- November 6, 2020
- Classification Date
- December 17, 2020
- Termination Date
- October 18, 2024
- Address
- 9115 Hague Rd, N/A, Indianapolis, IN, 46256-1025, United States
Description
Tina-quant C-Reactive Protein Gen.3, Catalog number 05172373190 - Product Usage: the in vitro quantitative determination of CRP in human serum and plasma on Roche automated clinical chemistry analyzers.
Reason
Roche confirmed customer complaints of low quality (QC) recovery and invalid calibrations for the Tina-quant C-Reactive Protein Gen. 3 on the cobas c701 and 702 modules. A discoloration (yellow color) was observed and is the result of cross contamination between the R1 and R3 reagents.
Code Info
CRPL3 - lot 42402301
Distribution
US Nationwide distribution including in the states of AL, CA, FL, GA, HI, IA, IL, IN, KY, MA, MD, MI, MN, MO, NJ, NY, OH, PA, SC, TN, TX, VA.
Quantity
699 units